5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schiffrin, EL; Touyz, RM; Turgeon, A | 1 |
| Park, JB; Schiffrin, EL | 2 |
3 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Body Weight
| Article | Year |
|---|---|
Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Dansyl Compounds; Endothelin Receptor Antagonists; Female; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Stroke | 2000 |
ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
Topics: Aldosterone; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Body Weight; Dansyl Compounds; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension; Hypertrophy; Infusions, Parenteral; Male; Mesenteric Arteries; Potassium; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; Vasoconstriction; Vasodilation | 2001 |
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
Topics: Aldosterone; Animals; Antihypertensive Agents; Aorta; Aortic Diseases; Blood Pressure; Body Weight; Cardiomyopathies; Collagen; Dansyl Compounds; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Heart; Hypertrophy; Male; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 2002 |